Nurix Therapeutics Presents Positive Results from the Ongoing Clinical Trial of Its BTK Degrader NX-5948 in Patients with Relapsed/Refractory Waldenstrom’s Macroglobulinemia
October 19, 2024 08:00 ET
|
Nurix Therapeutics, Inc.
NX-5948 demonstrated robust clinical activity with objective responses observed in 7 of 9 (77.8%) evaluable Waldenstrom’s patients in the ongoing Phase 1a/1b clinical trial Responses are durable and...
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
October 18, 2024 22:46 ET
|
Tevogen Bio Inc
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
Celularity Inc. Receives Notice from Nasdaq; Confirms Intention to File an Appeal
October 18, 2024 18:00 ET
|
Celularity Inc.
FLORHAM PARK, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing and commercializing placental-derived technologies,...
Village Farms International Provides Update on Nasdaq Listing
October 18, 2024 17:41 ET
|
Village Farms International, Inc.
VANCOUVER, British Columbia and ORLANDO, Fla., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) has received notification from The...
Three-year Results for EYLEA HD® (aflibercept) Injection 8 mg Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals in Patients with Diabetic Macular Edema
October 18, 2024 17:05 ET
|
Regeneron Pharmaceuticals, Inc.
88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual and anatomic improvements achieved in the first 96 weeks, in this extension study of the...
Oak Valley Bancorp Reports 3rd Quarter Results
October 18, 2024 17:00 ET
|
Oak Valley Community Bank
OAKDALE, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Oak Valley Bancorp (NASDAQ: OVLY) (the “Company”), the bank holding company for Oak Valley Community Bank and their Eastern Sierra Community Bank...
Arhaus Announces Showroom in Oklahoma City, Oklahoma
October 18, 2024 16:52 ET
|
Arhaus, Inc.
BOSTON HEIGHTS, Ohio, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Arhaus, a leader in artisan-crafted furniture and home décor, announces the opening of its new 17,000 square-foot showroom in Oklahoma...
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 18, 2024 16:31 ET
|
Chimerix, Inc.
DURHAM, N.C., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on October 16, 2024, the Compensation Committee of Chimerix’s Board of Directors granted an inducement...
DBV Technologies participera au prochain congrès de l'ACAAI 2024
October 18, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, le 18 octobre (22 :30 CEST) 2024 DBV Technologies participera au prochain congrès de l'ACAAI 2024 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock...
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
October 18, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, October 18, 2024 DBV Technologies to Participate in Upcoming ACAAI 2024 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a...